New developments in cervical cancer screening and prevention /

New developments in cervical cancer screening and prevention /

Saved in:
Bibliographic Details
Imprint:Oxford [England] ; Malden, MA, USA : Blackwell Science, 1997.
Description:xiv, 470 p. : ill. ; 25 cm.
Language:English
Subject:
Cervix uteri -- Cancer -- Diagnosis -- Congresses.
Cervix uteri -- Cancer -- Prevention -- Congresses.
Medical screening -- Congresses.
Cervix Neoplasms -- prevention & control -- Congresses.
Cervix Neoplasms -- epidemiology -- Congresses.
Mass Screening -- congresses.
Cytodiagnosis -- congresses.
Papovaviridae Infections -- prevention & control -- Congresses.
Cervix uteri -- Cancer -- Diagnosis.
Cervix uteri -- Cancer -- Prevention.
Medical screening.
Conference papers and proceedings.
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/3788791
Hidden Bibliographic Details
Other authors / contributors:Franco, Eduardo Luiz Fabiano.
Monsonégo, Joseph.
ISBN:0632047658
Notes:Papers based on a three day workshop held June 17-19, 1996, in Geneva, Switzerland.
Includes bibliographical references and index.

MARC

LEADER 00000cam a2200000 a 4500
001 3788791
003 ICU
005 20030527213500.0
008 961107s1997 enka b 101 0 eng c
010 |a  96037506  
020 |a 0632047658 
035 |a 96037506 
040 |a DNLM/DLC  |c DLC  |d DLC  |d OrLoB-B  |d OCoLC 
050 0 0 |a RC280.U8  |b N49 1997 
060 1 0 |a WP 480 1997 
082 0 0 |a 362.1/9699466  |2 21 
245 0 0 |a New developments in cervical cancer screening and prevention /  |c edited by Eduardo Franco and Joseph Monsonego. 
260 |a Oxford [England] ;  |a Malden, MA, USA :  |b Blackwell Science,  |c 1997. 
300 |a xiv, 470 p. :  |b ill. ;  |c 25 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
500 |a Papers based on a three day workshop held June 17-19, 1996, in Geneva, Switzerland. 
504 |a Includes bibliographical references and index. 
505 0 0 |t The Rationale: Cervical Cancer Control --  |g 1.  |t Human Papillomavirus and Cervical Cancer: Epidemiological Evidence /  |r N. Munoz --  |g 2.  |t Epidemiology of Cervical Human Papillomavirus Infection /  |r E. L. Franco, L. L. Villa and H. Richardson --  |g 3.  |t Geographical and Social Patterns of Cervical Cancer Incidence /  |r F. X. Bosch, S. de Sanjose and X. Castellsague --  |g 4.  |t The Male Role in Cervical Carcinogenesis: Lessons from the Studies in Colombia and Spain and a Challenge for the Future /  |r F. X. Bosch, N. Munoz and X. Castellsague --  |g 5.  |t Statistical Issues in Studies of Human Papillomavirus Infection and Cervical Cancer /  |r E. L. Franco --  |g 6.  |t The Epidemiological Basis for Evaluating Screening Policies /  |r D. M. Parkin --  |g 7.  |t Prevention Measures in the Third World: Are they Practical? /  |r R. Sankaranarayanan and P. Pisani --  |g 8.  |t Prevention of Sexually Transmitted Infections through Health Education and Counselling: A General Framework /  |r A. Meheus --  |g 9.  |t Biological Behaviour of Cervical Intraepithelial Neoplasia /  |r K. J. Syrjanen --  |g 10.  |t Optimal Management of Cervical Cancer Precursors: Low-Grade Squamous Intraepithelial Lesions /  |r A. Ferenczy --  |g 11.  |t Optimal Management of Cervical Cancer Precursors: High-Grade Lesions /  |r A. Ferenczy --  |g 12.  |t Glandular Lesions: An Increasing Problem /  |r A. Ferenczy --  |g 13.  |t Papillomavirus Infection and Neoplasia in Women Infected with Human Immunodeficiency Virus /  |r T. C. Wright, Jr. --  |g 14.  |t Performance of Cytology in Screening for Precursor Lesions and Early Cancer of the Uterine Cervix /  |r L. G. Koss --  |g 15.  |t The Bethesda System (TBS): Advantages and Pitfalls /  |r A. Ferenczy --  |g 16.  |t Quality Assurance in Cervical Cytopathology /  |r M. E. Sherman --  |g 17.  |t Error Rates in Cervical Cancer Screening: Causes and Consequences /  |r L. G. Koss --  |g 18.  |t Cervical Cancer Following Negative Smears /  |r E. McGoogan --  |g 19.  |t Organization, Monitoring and Use of Resources for Screening Programmes /  |r J. Patnick --  |g 20.  |t Cervical Screening by General Practitioners and Nurses and Information Feedback Systems /  |r J. Patnick --  |g 21.  |t Screening Programmes: Results and Expectations /  |r I. D. Duncan --  |g 22.  |t Screening for Cervical Cancer: Experience of the Nordic Countries /  |r M. Hakama --  |g 23.  |t Screening that Failed to Work /  |r J. Patnick --  |g 24.  |t Implementation and Evaluation of Cervical Cancer Screening Programmes in the European Union /  |r C. J. M. de Wolf --  |g 25.  |t Organization and Results of Cervical Cancer Screening in Europe Over the Past 20 Years /  |r C. J. M. de Wolf --  |g 26.  |t Spontaneous Screening: Benefits and Limitations /  |r J. Monsonego --  |g 27.  |t Is Cervical Cancer Cytological Screening Valuable in Developing Countries? /  |r R. Herrero, M. H. Schiffman and A. Hildesheim --  |g 28.  |t Screening in Cervical Cancer Prevention in Porto Alegre, Brazil: The Experience of a Programme in a Developing Country /  |r P. Naud, M. C. Bozzetti and J. C. Prolla --  |g 29.  |t Automation and Cervical Cytopathology: An Overview /  |r E. McGoogan --  |g 30.  |t Automation in Cervicovaginal Cytology: System Requirements and Benefits /  |r L. G. Koss --  |g 31.  |t Automated Screening Using the AutoPap 300 Device /  |r R. M. Richart, S. F. Patten, Jr. and J. S. J. Lee --  |g 32.  |t Liquid-based Cytology: Comparison of ThinPrep 2000 with Conventionally Prepared Pap Smears /  |r J. Linder --  |g 33.  |t The History of Neural Network Technology in Cytology /  |r M. E. Boon --  |g 34.  |t A Comparison of Automated and Manual Screening: Theoretical Considerations /  |r M. E. Sherman --  |g 35.  |t Cooperation of the Image Analyser and the Cytologist /  |r M. E. Boon --  |g 36.  |t Advantages and Limitations of Automated Screening Systems in Developing and Developed Countries /  |r E. McGoogan --  |g 37.  |t Methods of DNA Hybridization and their Clinical Applicability to Human Papillomavirus Detection /  |r A. T. Lorincz --  |g 38.  |t Human Papillomavirus Testing for Primary Cervical Cancer Screening /  |r C. J. L. M. Meijer, L. Rozendaal and J. C. van der Linden --  |g 39.  |t Human Papillomavirus DNA Testing Using Liquid-based Cytology /  |r A. Ferenczy and E. L. Franco --  |g 40.  |t Human Papillomavirus Testing for Diagnostic Triage of Minor-grade Cytological Abnormalities: The European Perspective /  |r T. A. J. Mould and A. Singer --  |g 41.  |t Use of Human Papillomavirus Typing for Quality Assurance of Cytological Diagnosis /  |r M. E. Sherman, M. H. Schiffman and A. T. Lorincz --  |g 42.  |t Estimates of the Cost Impact of Introducing Human Papillomavirus Testing into a Cervical Screening Programme /  |r J. Cuzick and P. Sasieni --  |g 43.  |t Viral Load as a Surrogate for Persistence in Cervical Human Papillomavirus Infection /  |r J. Cuzick --  |g 44.  |t Molecular Variant Analysis as a Tool in Natural History Studies of Human Papillomavirus Infection and Cervical Neoplasia /  |r L. L. Villa, P. Rahal and E. L. Franco --  |g 45.  |t Evaluation of Multiple Screening Techniques in a High-risk Area: The Guanacaste Project /  |r R. Herrero, M. H. Schiffman and C. Bratti --  |g 46.  |t Colposcopy as a Screening Tool for Cervical Cancer Detection: A Review /  |r R. Barrasso --  |g 47.  |t Adjuvant Tests to Cytology: Cervicography and the Polarprobe /  |r T. A. J. Mould and A. Singer --  |g 48.  |t Visual Inspection as a Screening Test for Cervical Cancer Control in Developing Countries /  |r R. Sankaranarayanan, B. Syamalakumari and R. Wesley --  |g 49.  |t Human Papillomavirus Vaccines and their Potential Use in the Prevention and Treatment of Cervical Neoplasia /  |r N. Munoz --  |g 50.  |t Animal Models for Evaluation of Human Papillomavirus Vaccines /  |r F. Breitburd, J. Salmon and G. Orth --  |g 51.  |t Induction of Human Papillomavirus-Specific Immune Response /  |r L. Qiao, A. M. Kaufmann and G. Maass --  |g 52.  |t Rapporteurs' Summary of Presentations /  |r E. L. Franco --  |g 53.  |t Highlights and Consensus /  |r E. L. Franco. 
650 0 |a Cervix uteri  |x Cancer  |x Diagnosis  |v Congresses.  |0 http://id.loc.gov/authorities/subjects/sh2010008898 
650 0 |a Cervix uteri  |x Cancer  |x Prevention  |v Congresses.  |0 http://id.loc.gov/authorities/subjects/sh2010008966 
650 0 |a Medical screening  |v Congresses.  |0 http://id.loc.gov/authorities/subjects/sh2010101300 
650 1 2 |a Cervix Neoplasms  |x prevention & control  |v Congresses. 
650 2 2 |a Cervix Neoplasms  |x epidemiology  |v Congresses. 
650 2 2 |a Mass Screening  |v congresses. 
650 2 2 |a Cytodiagnosis  |v congresses. 
650 2 2 |a Papovaviridae Infections  |x prevention & control  |v Congresses. 
650 7 |a Cervix uteri  |x Cancer  |x Diagnosis.  |2 fast  |0 http://id.worldcat.org/fast/fst00851517 
650 7 |a Cervix uteri  |x Cancer  |x Prevention.  |2 fast  |0 http://id.worldcat.org/fast/fst00851520 
650 7 |a Medical screening.  |2 fast  |0 http://id.worldcat.org/fast/fst01014632 
655 7 |a Conference papers and proceedings.  |2 fast  |0 http://id.worldcat.org/fast/fst01423772 
700 1 |a Franco, Eduardo Luiz Fabiano.  |0 http://id.loc.gov/authorities/names/n90691934  |1 http://viaf.org/viaf/41005604 
700 1 |a Monsonégo, Joseph.  |0 http://id.loc.gov/authorities/names/n89139430  |1 http://viaf.org/viaf/33135428 
901 |a ToCBNA 
903 |a HeVa 
035 |a (OCoLC)35927630 
929 |a cat 
999 f f |i 6ce3ceb1-775a-5ddc-984c-103f17791d86  |s 2873b28c-3364-5d39-9d95-a32f08827f4b 
928 |t Library of Congress classification  |a RC280.U8 N49 1997  |l JCL  |c JCL-Sci  |i 3659921 
927 |t Library of Congress classification  |a RC280.U8 N49 1997  |l JCL  |c JCL-Sci  |e CRERAR  |b 50768271  |i 6225303 
The John Crerar Library bookplate

Similar Items